COVID-19 大流行期间的流感和 RSV 发病率:一项来自医院即时检测的观察性研究。
Influenza and RSV incidence during COVID-19 pandemic-an observational study from in-hospital point-of-care testing.
机构信息
Department of Cardiology, Cardiology I, University Medical Center Mainz, Geb. 605, Langenbeckstr. 1, 55131, Mainz, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.
出版信息
Med Microbiol Immunol. 2021 Dec;210(5-6):277-282. doi: 10.1007/s00430-021-00720-7. Epub 2021 Oct 4.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has forced the implementation of unprecedented public health measures strategies which might also have a significant impact on the spreading of other viral pathogens such as influenza and Respiratory Syncytial Virus (RSV) . The present study compares the incidences of the most relevant respiratory viruses before and during the SARS-CoV-2 pandemic in emergency room patients. We analyzed the results of in total 14,946 polymerase chain reaction point-of-care tests (POCT-PCR) for Influenza A, Influenza B, RSV and SARS-CoV-2 in an adult and a pediatric emergency room between December 1, 2018 and March 31, 2021. Despite a fivefold increase in the number of tests performed, the positivity rate for Influenza A dropped from 19.32% (165 positives of 854 tests in 2018/19), 14.57% (149 positives of 1023 in 2019-20) to 0% (0 positives of 4915 tests) in 2020/21. In analogy, the positivity rate for Influenza B and RSV dropped from 0.35 to 1.47%, respectively, 10.65-21.08% to 0% for both in 2020/21. The positivity rate for SARS-CoV2 reached 9.74% (110 of 1129 tests performed) during the so-called second wave in December 2020. Compared to the two previous years, seasonal influenza and RSV incidence was eliminated during the COVID-19 pandemic. Corona-related measures and human behavior patterns could lead to a significant decline or even complete suppression of other respiratory viruses such as influenza and RSV.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行迫使实施了前所未有的公共卫生措施策略,这也可能对流感和呼吸道合胞病毒(RSV)等其他病毒病原体的传播产生重大影响。本研究比较了在 SARS-CoV-2 大流行之前和期间急诊患者中最相关的呼吸道病毒的发病率。我们分析了 2018 年 12 月 1 日至 2021 年 3 月 31 日期间在成人和儿科急诊室进行的总共 14946 项即时聚合酶链反应(POCT-PCR)检测的结果,用于检测流感 A、流感 B、RSV 和 SARS-CoV-2。尽管进行的检测数量增加了五倍,但流感 A 的阳性率从 2018/19 年的 19.32%(854 次检测中 165 次阳性)、2019-20 年的 14.57%(1023 次检测中 149 次阳性)降至 2020/21 年的 0%(4915 次检测中均未阳性)。类似地,流感 B 和 RSV 的阳性率分别从 0.35%降至 1.47%、10.65%-21.08%降至 2020/21 年的 0%。所谓的 2020 年 12 月第二波期间,SARS-CoV-2 的阳性率达到 9.74%(1129 次检测中 110 次阳性)。与前两年相比,COVID-19 大流行期间季节性流感和 RSV 发病率已消除。与冠状病毒相关的措施和人类行为模式可能导致其他呼吸道病毒(如流感和 RSV)的显著下降甚至完全抑制。